Bolt Biotherapeutics, Inc. (BOLT) vs Ensysce Biosciences, Inc. (ENSC)
A side-by-side comparison of Bolt Biotherapeutics, Inc. and Ensysce Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLT
Bolt Biotherapeutics, Inc.
$3.52HealthcareDelayed quote: Oct 6, 2026, 10:17 AM EDT
ENSC
Ensysce Biosciences, Inc.
$0.42HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — BOLT vs ENSC
growth of $100 · dividends reinvested · last 6yBOLT -99.5% (-58.1%/yr)ENSC -100.0% (-86.2%/yr)BOLT compounded faster over this window
Log scale — wide-divergence pair
BOLT ENSC
BOLT vs ENSC: by the numbers
- •BOLT is the larger company ($7M vs $7M market cap).
- •Both run net losses; BOLT's is the smaller (-611.47% vs -1084.23% net margin).
Metrics side by side
Valuation
| Metric | BOLT | ENSC |
|---|---|---|
| P/S ratio | 1.44 | 5.60 |
| P/B ratio | 0.54 | N/A |
Profitability
| Metric | BOLT | ENSC |
|---|---|---|
| Gross margin | 80.62% | 0.00% |
| Operating margin | -450.07% | 0.00% |
| Net margin | -611.47% | -1084.23% |
| ROE | -227.37% | N/A |
| ROIC | -90.17% | N/A |
Growth (annualized)
| Metric | BOLT | ENSC |
|---|---|---|
| Total return CAGR (5Y) | -57.61% | -86.22% |
Frequently asked
- How have BOLT and ENSC total returns compared?
- Over the past 5 years, BOLT delivered -57.61% and ENSC delivered -86.22% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.